TSS
PLX icon

Two Sigma Securities’s Protalix BioTherapeutics PLX Stock Holding History

Two Sigma Securities’s Portfolio PLX Stock Details PLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.5K Buy
+17,795
New +$37.7K ﹤0.01% 1406
2026
Q1 		– Sell
-39,811
Closed -$71.7K – 2076
2025
Q4 		$71.7K Buy
+39,811
New +$81.4K 0.01% 1022
2024
Q3 		– Sell
-52,320
Closed -$61.2K – 3463
2024
Q2 		$61.2K Sell
52,320
-32,993
-39% -$39K ﹤0.01% 2547
2024
Q1 		$107K Buy
85,313
+40,839
+92% +$61K ﹤0.01% 2467
2023
Q4 		$79.2K Buy
+44,474
New +$69.2K ﹤0.01% 2546
2023
Q3 		– Sell
-15,276
Closed -$30.6K – 3352
2023
Q2 		$30.6K Sell
15,276
-5,484
-26% -$13.1K ﹤0.01% 2457
2023
Q1 		$43.6K Buy
+20,760
New +$36.4K ﹤0.01% 2291
2018
Q1 		– Sell
-5,713
Closed -$38K – 2889
2017
Q4 		$38K Buy
5,713
+950
+20% +$6.41K ﹤0.01% 1567
2017
Q3 		$28K Buy
+4,763
New +$30.5K ﹤0.01% 797
2015
Q2 		– Sell
-1,115
Closed -$20K – 244
2015
Q1 		$20K Buy
+1,115
New +$21.8K 0.02% 177

Other funds holding PLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SWP
Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Two Sigma Securities's PLX Position: Q2 2026 in Review

Two Sigma Securities opened a new position in Protalix BioTherapeutics (PLX) in Q2 2026: 17,795 shares worth $41.5K. The stake represents ﹤0.01% of the portfolio and ranks #1406 among its holdings. This is a return to the name: Two Sigma Securities previously reported a position in PLX as recently as Q4 2025.

Two Sigma Securities first reported a position in PLX in Q1 2015 and has held it in 10 quarters since. The position peaked at $107K in Q1 2024. 102 funds tracked by Wall St. Rank hold PLX as of Q2 2026.

  • Two Sigma Securities held 17,795 shares of Protalix BioTherapeutics worth $41.5K as of Q2 2026.
  • Protalix BioTherapeutics was a new Two Sigma Securities position in Q2 2026.
  • Protalix BioTherapeutics made up ﹤0.01% of Two Sigma Securities's portfolio in Q2 2026, its #1406 holding.
  • Two Sigma Securities first reported a position in Protalix BioTherapeutics in Q1 2015 and has held it in 10 quarters since.
  • Two Sigma Securities's Protalix BioTherapeutics position peaked at $107K in Q1 2024.
  • 102 funds tracked by Wall St. Rank held Protalix BioTherapeutics as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.